Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 1: Synthesis of triplet drugs with morphinan skeletons
摘要:
We synthesized symmetrical and nonsymmetrical triplet drugs with 1,3,5-trioxazatriquinane skeletons. The isolation of key intermediates, oxazoline dimers, made it possible to effectively produce nonsymmetrical triplets. Among the synthesized triplets, KNT-93, composed of three identical opioid mu receptor agonists, showed dose-dependent antinociception via the mu receptor. The effect was 56-fold more potent than that of morphine, a representative mu agonist. The profound analgesic effect induced by KNT-93 might result from simultaneous occupation of three mu opioid receptors. (C) 2011 Elsevier Ltd. All rights reserved.
Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 1: Synthesis of triplet drugs with morphinan skeletons
摘要:
We synthesized symmetrical and nonsymmetrical triplet drugs with 1,3,5-trioxazatriquinane skeletons. The isolation of key intermediates, oxazoline dimers, made it possible to effectively produce nonsymmetrical triplets. Among the synthesized triplets, KNT-93, composed of three identical opioid mu receptor agonists, showed dose-dependent antinociception via the mu receptor. The effect was 56-fold more potent than that of morphine, a representative mu agonist. The profound analgesic effect induced by KNT-93 might result from simultaneous occupation of three mu opioid receptors. (C) 2011 Elsevier Ltd. All rights reserved.
An α-hydroxyaldehyde derived from naltrexone was converted to an oxazoline dimer with ammonium chloride and sodium acetate in MeOH under reflux. The resulting dimer was treated with dl-camphorsulfonic acid in CHCl3 to give the trimer. The method for trimersynthesis was also applied to general α-hydroxyaldehydes to afford trimers in good yield.